GDNF and Parkinson disease: Earlier investigations have established that harpagoside exerts neuroprotective properties in both in vivo and in vitro PD models through glial cell line-derived neurotrophic factor (GDNF) upregulation and mitochondrial function preservation (Lang and Xiong, 2025; Sun et al., 2012).